Related Experiment Video
Updated: Aug 14, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Thyroid Cancer: From Potential Drivers to Real Modulators
Shafiya Imtiaz Rafiqi1,2, Juan Carlos Jaume1,2
1Department of Medicine, Edward Hines Jr. VA Hospital, Hines, IL 60141, USA.
Cancers
|August 13, 2026
Summary
Cancer immunotherapy advances understanding of the tumor immune microenvironment (TIME). This review explores TIME
Area of Science:
- Oncology and Immunology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- Cancer immunotherapy has revolutionized oncology, shifting focus from precision medicine to immune system activation.
- Understanding the tumor immune microenvironment (TIME) is crucial for overcoming cancer's genetic diversity.
- Thyroid cancer research has lagged in exploring the TIME, focusing more on genetic mutations.
Purpose of the Study:
- To review the molecular and cellular mechanisms shaping the thyroid tumor immune microenvironment.
- To highlight how oncogenic signaling, stromal remodeling, and metabolic reprogramming influence tumor immunity.
- To explore emerging strategies for reengineering the TIME to improve therapeutic outcomes in thyroid cancer.
Main Methods:
- Review of recent findings on immune cell composition in thyroid malignancies.
- Analysis of molecular and cellular mechanisms within the TIME.
- Exploration of emerging therapeutic strategies targeting the TIME.
Main Results:
- The TIME, comprising immune cells and signaling molecules, dynamically interacts with tumor growth, genetics, and treatment.
- This interaction influences thyroid cancer heterogeneity, from aggressive ATC to indolent PTC.
- Mapping spatial and temporal TIME changes can guide therapies against immune evasion.
Conclusions:
- A deeper understanding of the TIME is critical for advancing thyroid cancer immunotherapy.
- Integrated, combinational approaches incorporating personalized immunotherapy are emerging.
- Reengineering the TIME offers promising avenues for improved therapeutic outcomes.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...